BIOGEN INC. Foreign Currency Transaction Gain (Loss), before Tax
BIOGEN INC. (BIIB) reported Foreign Currency Transaction Gain (Loss), before Tax of -$6.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-04-29
- BIOGEN INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$6.50M, a 271.05% decline year-over-year.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $45.50M, a 19.47% decline year-over-year.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$10.30M.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was -$10.40M.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $28.60M, a 7.44% decline from fiscal 2024.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was $30.90M, a 38.69% decline from fiscal 2023.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $50.40M, a 41.97% increase from fiscal 2022.
- BIOGEN INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $35.50M, a 58.48% increase from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | -$6.50M 10-Q · filed 2026-04-29 | $39.00M derived: sum of 2 quarters · filed 2026-04-29 | $28.70M derived: sum of 3 quarters · filed 2026-04-29 | $18.30M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2025-12-31 | $45.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $35.20M derived: sum of 2 quarters · filed 2026-02-06 | $24.80M derived: sum of 3 quarters · filed 2026-02-06 | $28.60M 10-K · filed 2026-02-06 | |
| 2025-09-30 | -$10.30M 10-Q · filed 2025-10-30 | -$20.70M derived: sum of 2 quarters · filed 2025-10-30 | -$16.90M 10-Q · filed 2025-10-30 | $39.60M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2025-06-30 | -$10.40M 10-Q · filed 2025-07-31 | -$6.60M 10-Q · filed 2025-07-31 | $49.90M derived: sum of 3 quarters · filed 2026-04-29 | $45.00M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2025-03-31 | $3.80M 10-Q · filed 2026-04-29 | $60.30M derived: sum of 2 quarters · filed 2026-04-29 | $55.40M derived: sum of 3 quarters · filed 2026-04-29 | $44.10M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $56.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $51.60M derived: sum of 2 quarters · filed 2026-02-06 | $40.30M derived: sum of 3 quarters · filed 2026-02-06 | $30.90M 10-K · filed 2026-02-06 | |
| 2024-09-30 | -$4.90M 10-Q · filed 2025-10-30 | -$16.20M derived: sum of 2 quarters · filed 2025-10-30 | -$25.60M 10-Q · filed 2025-10-30 | $55.60M derived: sum of 4 quarters · filed 2026-02-06 | |
| 2024-06-30 | -$11.30M 10-Q · filed 2025-07-31 | -$20.70M 10-Q · filed 2025-07-31 | $60.50M derived: sum of 3 quarters · filed 2026-02-06 | $49.10M derived: sum of 4 quarters · filed 2026-02-06 | |
| 2024-03-31 | -$9.40M 10-Q · filed 2025-05-01 | $71.80M derived: sum of 2 quarters · filed 2026-02-06 | $60.40M derived: sum of 3 quarters · filed 2026-02-06 | $51.70M derived: sum of 4 quarters · filed 2026-02-06 | |
| 2023-12-31 | $81.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $69.80M derived: sum of 2 quarters · filed 2026-02-06 | $61.10M derived: sum of 3 quarters · filed 2026-02-06 | $50.40M 10-K · filed 2026-02-06 | |
| 2023-09-30 | -$11.40M 10-Q · filed 2024-10-30 | -$20.10M derived: sum of 2 quarters · filed 2024-10-30 | -$30.80M 10-Q · filed 2024-10-30 | $43.70M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | -$8.70M 10-Q · filed 2024-08-01 | -$19.40M 10-Q · filed 2024-08-01 | $55.10M derived: sum of 3 quarters · filed 2025-02-12 | $43.60M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | -$10.70M 10-Q · filed 2024-04-24 | $63.80M derived: sum of 2 quarters · filed 2025-02-12 | $52.30M derived: sum of 3 quarters · filed 2025-02-12 | $33.10M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | $74.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $63.00M derived: sum of 2 quarters · filed 2025-02-12 | $43.80M derived: sum of 3 quarters · filed 2025-02-12 | $35.50M 10-K · filed 2025-02-12 | |
| 2022-09-30 | -$11.50M 10-Q · filed 2023-11-08 | -$30.70M derived: sum of 2 quarters · filed 2023-11-08 | -$39.00M 10-Q · filed 2023-11-08 | $6.50M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | -$19.20M 10-Q · filed 2023-07-25 | -$27.50M 10-Q · filed 2023-07-25 | $18.00M derived: sum of 3 quarters · filed 2024-02-14 | $4.30M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | -$8.30M 10-Q · filed 2023-04-25 | $37.20M derived: sum of 2 quarters · filed 2024-02-14 | $23.50M derived: sum of 3 quarters · filed 2024-02-14 | $22.70M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-31 | $45.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $31.80M derived: sum of 2 quarters · filed 2024-02-14 | $31.00M derived: sum of 3 quarters · filed 2024-02-14 | $22.40M 10-K · filed 2024-02-14 | -$22.40M 10-K · filed 2022-02-03 |
| 2021-09-30 | -$13.70M 10-Q · filed 2022-10-25 | -$14.50M derived: sum of 2 quarters · filed 2022-10-25 | -$23.10M 10-Q · filed 2022-10-25 | -$7.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-06-30 | -$800.00K 10-Q · filed 2022-07-20 | -$9.40M 10-Q · filed 2022-07-20 | $6.70M derived: sum of 3 quarters · filed 2023-02-15 | $9.80M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-03-31 | -$8.60M 10-Q · filed 2022-05-03 | $7.50M derived: sum of 2 quarters · filed 2023-02-15 | $10.60M derived: sum of 3 quarters · filed 2023-02-15 | $21.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2020-12-31 | $16.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $19.20M derived: sum of 2 quarters · filed 2023-02-15 | $29.60M derived: sum of 3 quarters · filed 2023-02-15 | $10.70M 10-K · filed 2023-02-15 | -$10.70M 10-K · filed 2021-02-03 |
| 2020-09-30 | $3.10M 10-Q · filed 2021-10-20 | $13.50M derived: sum of 2 quarters · filed 2021-10-20 | -$5.40M 10-Q · filed 2021-10-20 | -$7.70M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-06-30 | $10.40M 10-Q · filed 2021-07-22 | -$8.50M 10-Q · filed 2021-07-22 | -$10.80M derived: sum of 3 quarters · filed 2022-02-03 | -$15.00M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-03-31 | -$18.90M 10-Q · filed 2021-04-22 | -$21.20M derived: sum of 2 quarters · filed 2022-02-03 | -$25.40M derived: sum of 3 quarters · filed 2022-02-03 | -$23.70M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2019-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$6.50M derived: sum of 2 quarters · filed 2022-02-03 | -$4.80M derived: sum of 3 quarters · filed 2022-02-03 | -$7.00M 10-K · filed 2022-02-03 | |
| 2019-09-30 | -$4.20M 10-Q · filed 2020-10-21 | -$2.50M derived: sum of 2 quarters · filed 2020-10-21 | -$4.70M 10-Q · filed 2020-10-21 | -$800.00K derived: sum of 4 quarters · filed 2021-02-03 | |
| 2019-06-30 | $1.70M 10-Q · filed 2020-07-22 | -$500.00K 10-Q · filed 2020-07-22 | $3.40M derived: sum of 3 quarters · filed 2021-02-03 | $3.60M derived: sum of 4 quarters · filed 2021-02-03 | |
| 2019-03-31 | -$2.20M 10-Q · filed 2020-04-23 | $1.70M derived: sum of 2 quarters · filed 2021-02-03 | $1.90M derived: sum of 3 quarters · filed 2021-02-03 | -$11.10M derived: sum of 4 quarters · filed 2021-02-03 | |
| 2018-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $4.10M derived: sum of 2 quarters · filed 2021-02-03 | -$8.90M derived: sum of 3 quarters · filed 2021-02-03 | -$9.90M 10-K · filed 2021-02-03 | |
| 2018-09-30 | $200.00K 10-Q · filed 2019-10-22 | -$12.80M derived: sum of 2 quarters · filed 2019-10-22 | -$13.80M 10-Q · filed 2019-10-22 | -$15.90M derived: sum of 4 quarters · filed 2020-02-06 | |
| 2018-06-30 | -$13.00M 10-Q · filed 2019-07-24 | -$14.00M 10-Q · filed 2019-07-24 | -$16.10M derived: sum of 3 quarters · filed 2020-02-06 | -$9.40M derived: sum of 4 quarters · filed 2020-02-06 | |
| 2018-03-31 | -$1.00M 10-Q · filed 2019-04-24 | -$3.10M derived: sum of 2 quarters · filed 2020-02-06 | $3.60M derived: sum of 3 quarters · filed 2020-02-06 | $1.30M derived: sum of 4 quarters · filed 2020-02-06 | |
| 2017-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $4.60M derived: sum of 2 quarters · filed 2020-02-06 | $2.30M derived: sum of 3 quarters · filed 2020-02-06 | $6.30M 10-K · filed 2020-02-06 | |
| 2017-09-30 | $6.70M 10-Q · filed 2018-10-23 | $4.40M derived: sum of 2 quarters · filed 2018-10-23 | $8.40M 10-Q · filed 2018-10-23 | $1.20M derived: sum of 4 quarters · filed 2019-02-06 | |
| 2017-06-30 | -$2.30M 10-Q · filed 2018-07-24 | $1.70M 10-Q · filed 2018-07-24 | -$5.50M derived: sum of 3 quarters · filed 2019-02-06 | -$10.40M derived: sum of 4 quarters · filed 2019-02-06 | |
| 2017-03-31 | $4.00M 10-Q · filed 2018-04-24 | -$3.20M derived: sum of 2 quarters · filed 2019-02-06 | -$8.10M derived: sum of 3 quarters · filed 2019-02-06 | -$7.90M derived: sum of 4 quarters · filed 2019-02-06 | |
| 2016-12-31 | -$7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$12.10M derived: sum of 2 quarters · filed 2019-02-06 | -$11.90M derived: sum of 3 quarters · filed 2019-02-06 | -$9.80M 10-K · filed 2019-02-06 | |
| 2016-09-30 | -$4.90M 10-Q · filed 2017-10-24 | -$4.70M derived: sum of 2 quarters · filed 2017-10-24 | -$2.60M 10-Q · filed 2017-10-24 | -$16.50M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2016-06-30 | $200.00K 10-Q · filed 2017-07-25 | $2.30M 10-Q · filed 2017-07-25 | -$11.60M derived: sum of 3 quarters · filed 2018-02-01 | -$15.90M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2016-03-31 | $2.10M 10-Q · filed 2017-04-25 | -$11.80M derived: sum of 2 quarters · filed 2018-02-01 | -$16.10M derived: sum of 3 quarters · filed 2018-02-01 | -$17.60M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2015-12-31 | -$13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$18.20M derived: sum of 2 quarters · filed 2018-02-01 | -$19.70M derived: sum of 3 quarters · filed 2018-02-01 | -$32.70M 10-K · filed 2018-02-01 | |
| 2015-09-30 | -$4.30M 10-Q · filed 2016-10-26 | -$5.80M derived: sum of 2 quarters · filed 2016-10-26 | -$18.80M 10-Q · filed 2016-10-26 | -$20.90M derived: sum of 4 quarters · filed 2017-02-02 | |
| 2015-06-30 | -$1.50M 10-Q · filed 2016-07-21 | -$14.50M 10-Q · filed 2016-07-21 | -$16.60M derived: sum of 3 quarters · filed 2017-02-02 | -$21.40M derived: sum of 4 quarters · filed 2017-02-02 | |
| 2015-03-31 | -$13.00M 10-Q · filed 2016-04-21 | -$15.10M derived: sum of 2 quarters · filed 2017-02-02 | -$19.90M derived: sum of 3 quarters · filed 2017-02-02 | -$21.30M derived: sum of 4 quarters · filed 2017-02-02 | |
| 2014-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$6.90M derived: sum of 2 quarters · filed 2017-02-02 | -$8.30M derived: sum of 3 quarters · filed 2017-02-02 | -$11.60M 10-K · filed 2017-02-02 | |
| 2014-09-30 | -$4.80M 10-Q · filed 2015-10-21 | -$6.20M derived: sum of 2 quarters · filed 2015-10-21 | -$9.50M 10-Q · filed 2015-10-21 | -$13.70M derived: sum of 4 quarters · filed 2016-02-03 | |
| 2014-06-30 | -$1.40M 10-Q · filed 2015-07-24 | -$4.70M 10-Q · filed 2015-07-24 | -$8.90M derived: sum of 3 quarters · filed 2016-02-03 | -$12.00M derived: sum of 4 quarters · filed 2016-02-03 | |
| 2014-03-31 | -$3.30M 10-Q · filed 2015-04-24 | -$7.50M derived: sum of 2 quarters · filed 2016-02-03 | -$10.60M derived: sum of 3 quarters · filed 2016-02-03 | -$15.90M derived: sum of 4 quarters · filed 2016-02-03 | |
| 2013-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$7.30M derived: sum of 2 quarters · filed 2016-02-03 | -$12.60M derived: sum of 3 quarters · filed 2016-02-03 | -$15.20M 10-K · filed 2016-02-03 | |
| 2013-09-30 | -$3.10M 10-Q · filed 2014-10-22 | -$8.40M derived: sum of 2 quarters · filed 2014-10-22 | -$11.00M 10-Q · filed 2014-10-22 | -$13.70M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2013-06-30 | -$5.30M 10-Q · filed 2014-07-23 | -$7.90M 10-Q · filed 2014-07-23 | -$10.60M derived: sum of 3 quarters · filed 2015-02-04 | -$10.50M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2013-03-31 | -$2.60M 10-Q · filed 2014-04-23 | -$5.30M derived: sum of 2 quarters · filed 2015-02-04 | -$5.20M derived: sum of 3 quarters · filed 2015-02-04 | -$6.50M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2012-12-31 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$2.60M derived: sum of 2 quarters · filed 2015-02-04 | -$3.90M derived: sum of 3 quarters · filed 2015-02-04 | -$2.50M 10-K · filed 2015-02-04 | |
| 2012-09-30 | $100.00K 10-Q · filed 2013-10-28 | -$1.20M derived: sum of 2 quarters · filed 2013-10-28 | $200.00K 10-Q · filed 2013-10-28 | -$300.00K derived: sum of 4 quarters · filed 2014-02-06 | |
| 2012-06-30 | -$1.30M 10-Q · filed 2013-07-25 | $100.00K 10-Q · filed 2013-07-25 | -$400.00K derived: sum of 3 quarters · filed 2014-02-06 | -$5.20M derived: sum of 4 quarters · filed 2014-02-06 | |
| 2012-03-31 | $1.40M 10-Q · filed 2013-04-25 | $900.00K derived: sum of 2 quarters · filed 2014-02-06 | -$3.90M derived: sum of 3 quarters · filed 2014-02-06 | -$4.50M derived: sum of 4 quarters · filed 2014-02-06 | |
| 2011-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$5.30M derived: sum of 2 quarters · filed 2014-02-06 | -$5.90M derived: sum of 3 quarters · filed 2014-02-06 | -$6.30M 10-K · filed 2014-02-06 | |
| 2011-09-30 | -$4.80M 10-Q · filed 2012-10-25 | -$5.40M derived: sum of 2 quarters · filed 2012-10-25 | -$5.80M 10-Q · filed 2012-10-25 | -$6.10M derived: sum of 4 quarters · filed 2013-02-05 | |
| 2011-06-30 | -$600.00K 10-Q · filed 2012-07-24 | -$1.00M 10-Q · filed 2012-07-24 | -$1.30M derived: sum of 3 quarters · filed 2013-02-05 | -$4.80M derived: sum of 4 quarters · filed 2013-02-05 | |
| 2011-03-31 | -$400.00K 10-Q · filed 2012-05-01 | -$700.00K derived: sum of 2 quarters · filed 2013-02-05 | -$4.20M derived: sum of 3 quarters · filed 2013-02-05 | -$4.90M derived: sum of 4 quarters · filed 2013-02-05 | |
| 2010-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | -$3.80M derived: sum of 2 quarters · filed 2013-02-05 | -$4.50M derived: sum of 3 quarters · filed 2013-02-05 | -$3.50M 10-K · filed 2013-02-05 | |
| 2010-09-30 | -$3.50M 10-Q · filed 2011-10-28 | -$4.20M derived: sum of 2 quarters · filed 2011-10-28 | -$3.20M 10-Q · filed 2011-10-28 | -$2.40M derived: sum of 4 quarters · filed 2012-02-03 | |
| 2010-06-30 | -$700.00K 10-Q · filed 2011-07-26 | $300.00K 10-Q · filed 2011-07-26 | $1.10M derived: sum of 3 quarters · filed 2012-02-03 | $4.30M derived: sum of 4 quarters · filed 2012-02-03 | |
| 2010-03-31 | $1.00M 10-Q · filed 2011-04-21 | $1.80M derived: sum of 2 quarters · filed 2012-02-03 | $5.00M derived: sum of 3 quarters · filed 2012-02-03 | $8.60M derived: sum of 4 quarters · filed 2012-02-03 | |
| 2009-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $4.00M derived: sum of 2 quarters · filed 2012-02-03 | $7.60M derived: sum of 3 quarters · filed 2012-02-03 | $11.40M 10-K · filed 2012-02-03 | |
| 2009-09-30 | $3.20M 10-Q · filed 2010-10-26 | $6.80M derived: sum of 2 quarters · filed 2010-10-26 | $10.60M 10-Q · filed 2010-10-26 | ||
| 2009-06-30 | $3.60M 10-Q · filed 2010-07-20 | $6.50M 10-Q · filed 2010-07-20 | |||
| 2008-12-31 | -$9.80M 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |